Unearthing the Janus-face cholesterogenesis pathways in cancer.

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Biology

Background:

• Cholesterol biosynthesis is essential in eukaryotes, particularly human metabolism.
• Deregulation of cholesterol biosynthesis is implicated in cancer cell viability.
• Cholesterol's amphipathic nature is crucial for cell membrane integrity and function.

Purpose of the Study:

• To examine human cholesterol biosynthesis pathways, including genes, enzymes, and intermediates.
• To compare the effects of proximal and distal cholesterol biosynthesis inhibitors on normal and cancer cells.
• To explore the therapeutic implications of targeting cholesterol biosynthesis in cancer.

Main Methods:

• Review of cholesterol biosynthetic genes, enzymes, and intermediates.
• Comparative analysis of proximal and distal cholesterol biosynthesis inhibitors.
• Assessment of inhibitor effects on normal and cancer cell growth and metabolism.

Main Results:

• Cholesterol biosynthesis pathways are complex, with distinct branches (Bloch, Kandutsch-Russell).
• Inhibitor studies reveal potential roles for disrupted cholesterol biosynthesis in cancer development.
• Targeting specific enzymes in cholesterol synthesis impacts cancer cell viability.

Conclusions:

• Disrupted cholesterol biosynthesis, alongside imported cholesterol, may contribute to cancer development.
• Inhibitors of cholesterol biosynthesis demonstrate chemotherapeutic potential.
• Understanding cholesterol metabolism is key to developing novel cancer therapies.